Medicine guide
LIBTAYO
As listed in the register: LIBTAYO 350 mg, solution à diluer pour perfusion
350 mg · solution à diluer pour perfusion
- Prescription only
- Active substance
- Cémiplimab
- Made by
- REGENERON IRELAND DESIGNATED ACTIVITY COMPANY (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | REGENERON IRELAND DESIGNATED ACTIVITY COMPANY (IRLANDE) |
|---|---|
| Active substance | Cémiplimab |
| Strength | 350 mg |
| Form | solution à diluer pour perfusion |
| Route | intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/19/1376 |
| Name in the register | LIBTAYO 350 mg, solution à diluer pour perfusion |
| Packs | 1 flacon en verre de 7 mL |
| CIS | 61660291 |
| CIP13 | 3400955067283 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).